Cargando…
HCV Detection, Discrimination, and Genotyping Technologies
According to the World Health Organization (WHO), 71 million people were living with Hepatitis C virus (HCV) infection worldwide in 2015. Each year, about 399,000 HCV-infected people succumb to cirrhosis, hepatocellular carcinoma, and liver failure. Therefore, screening of HCV infection with simple,...
Autores principales: | Warkad, Shrikant Dashrath, Nimse, Satish Balasaheb, Song, Keum-Soo, Kim, Taisun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210034/ https://www.ncbi.nlm.nih.gov/pubmed/30322029 http://dx.doi.org/10.3390/s18103423 |
Ejemplares similares
-
Development of a Method for Screening and Genotyping
of HCV 1a, 1b, 2, 3, 4, and 6 Genotypes
por: Warkad, Shrikant Dashrath, et al.
Publicado: (2020) -
Developments in the HCV Screening Technologies Based on the Detection of Antigens and Antibodies
por: Warkad, Shrikant Dashrath, et al.
Publicado: (2019) -
A Novel Method That Allows SNP Discrimination with 160:1 Ratio for Biosensors Based on DNA-DNA Hybridization
por: Nimse, Satish Balasaheb, et al.
Publicado: (2021) -
ID-Checker Technology
for the Highly Selective Macroscale
Delivery of Anticancer
Agents to the Cancer Cells
por: Song, Keum-soo, et al.
Publicado: (2022) -
Performance of 6 HCV genotyping 9G test for HCV genotyping in clinical samples
por: Warkad, Shrikant Dasharath, et al.
Publicado: (2018)